218,264 Axon Enterprise, Inc $AXON Shares Purchased by Ritholtz Wealth Management

Ritholtz Wealth Management lifted its position in Axon Enterprise, Inc (NASDAQ:AXON) by 10,951.5% in the third quarter, according to its most recent Form 13F filing with the SEC. The firm owned 220,257 shares of the biotechnology company’s stock after purchasing an additional 218,264 shares during the period. Axon Enterprise accounts for about 1.3% of Ritholtz Wealth Management’s investment portfolio, making the stock its 17th biggest position. Ritholtz Wealth Management’s holdings in Axon Enterprise were worth $93,063,000 at the end of the most recent reporting period.

A number of other large investors have also recently modified their holdings of the company. UNIVEST FINANCIAL Corp purchased a new stake in shares of Axon Enterprise in the 3rd quarter worth $12,961,000. NBH Bank grew its position in shares of Axon Enterprise by 5,493.8% during the 3rd quarter. NBH Bank now owns 10,908 shares of the biotechnology company’s stock worth $4,609,000 after buying an additional 10,713 shares in the last quarter. First Command Advisory Services Inc. grew its position in shares of Axon Enterprise by 10,431.1% during the 3rd quarter. First Command Advisory Services Inc. now owns 7,793 shares of the biotechnology company’s stock worth $3,293,000 after buying an additional 7,719 shares in the last quarter. Silver Grove Financial Group Inc. increased its stake in shares of Axon Enterprise by 21,088.0% during the third quarter. Silver Grove Financial Group Inc. now owns 5,297 shares of the biotechnology company’s stock valued at $2,238,000 after buying an additional 5,272 shares during the period. Finally, Keybank National Association OH increased its stake in shares of Axon Enterprise by 68,460.5% during the third quarter. Keybank National Association OH now owns 698,632 shares of the biotechnology company’s stock valued at $295,186,000 after buying an additional 697,613 shares during the period. Hedge funds and other institutional investors own 79.08% of the company’s stock.

More Axon Enterprise News

Investors following AXON have been watching these news items:

• Positive Sentiment: Northland maintained a $540 price target despite Axon’s steep decline from its August high, signaling that at least one analyst sees meaningful potential upside. A price target is an estimate, not a guarantee. Axon Is Down 52% From Its August High. Northland Still Sees $540
• Positive Sentiment: Axon’s integrated public-safety hardware and software ecosystem, along with continued revenue growth, are cited as reasons it could remain a long-term growth company despite its 2026 share-price decline. 3 Superior Growth Stocks That Can Outperform for the Next 10 Years
• Negative Sentiment: Several law firms have announced investigations into potential securities-law claims related to Axon’s earnings report. These are allegations under investigation, not findings of wrongdoing, but add a source of uncertainty for investors. Levi & Korsinsky investor investigation notice

Axon Enterprise Trading Up 4.3%

Shares of NASDAQ:AXON opened at $315.42 on Thursday. Axon Enterprise, Inc has a 12-month low of $291.45 and a 12-month high of $665.07. The business’s fifty day simple moving average is $426.24 and its 200-day simple moving average is $470.65. The company has a market capitalization of $25.68 billion, a PE ratio of 101.10, a P/E/G ratio of 5.75 and a beta of 1.48. The company has a current ratio of 3.00, a quick ratio of 2.60 and a debt-to-equity ratio of 0.76.

Axon Enterprise (NASDAQ:AXON) last released its quarterly earnings results on Thursday, November 5th. The biotechnology company reported $1.72 EPS for the quarter, missing the consensus estimate of $1.89 by ($0.17). The company had revenue of $908.55 million during the quarter, compared to the consensus estimate of $934.33 million. Axon Enterprise had a return on equity of 3.87% and a net margin of 7.56%. The company’s revenue was up 27.8% on a year-over-year basis. During the same period in the previous year, the firm posted $1.17 earnings per share. As a group, equities research analysts predict that Axon Enterprise, Inc will post 2.10 earnings per share for the current fiscal year.

Insider Buying and Selling

In other Axon Enterprise news, insider Isaiah Fields sold 1,017 shares of Axon Enterprise stock in a transaction dated Friday, September 11th. The stock was sold at an average price of $480.45, for a total value of $488,617.65. Following the transaction, the insider owned 56,264 shares in the company, valued at $27,032,038.80. The trade was a 1.78% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, insider Jeffrey Kunins sold 9,605 shares of the business’s stock in a transaction dated Friday, August 21st. The stock was sold at an average price of $626.70, for a total transaction of $6,019,453.50. Following the completion of the transaction, the insider owned 97,761 shares of the company’s stock, valued at $61,266,818.70. This represents a 8.95% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Insiders have sold 37,397 shares of company stock worth $21,234,034 over the last ninety days. 4.20% of the stock is currently owned by company insiders.

Analyst Ratings Changes

Several analysts recently weighed in on AXON shares. JPMorgan Chase & Co. decreased their price objective on Axon Enterprise from $755.00 to $610.00 and set an “overweight” rating for the company in a report on Friday, November 6th. Barclays dropped their target price on shares of Axon Enterprise from $688.00 to $507.00 and set an “overweight” rating on the stock in a report on Monday. Argus raised their target price on shares of Axon Enterprise from $460.00 to $600.00 and gave the company a “buy” rating in a research report on Thursday, September 3rd. Zacks Research lowered shares of Axon Enterprise from a “strong-buy” rating to a “hold” rating in a report on Tuesday, November 3rd. Finally, Piper Sandler restated an “overweight” rating and issued a $540.00 price target (down from $561.00) on shares of Axon Enterprise in a report on Friday, November 6th. Thirteen analysts have rated the stock with a Buy rating and four have given a Hold rating to the company. Based on data from MarketBeat, the stock presently has an average rating of “Moderate Buy” and an average price target of $612.18.

About Axon Enterprise

Axon Enterprise develops technology and services for public safety agencies. Its products include TASER conducted-energy weapons, body-worn and in-car cameras, and related hardware designed to support law enforcement and other safety professionals. The company also provides cloud-based software for managing digital evidence, records and operational workflows. Its Axon Evidence platform helps agencies store, organize and share video and other evidence, while its broader software offerings include tools for dispatch and records management.